Chemistry:Methylenedioxycathinone

From HandWiki
Short description: Chemical compound
Methylenedioxycathinone
MDC.png
Clinical data
Routes of
administration
Oral, Insufflation, Rectal
ATC code
  • none
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC10H11NO3
Molar mass193.202 g·mol−1
3D model (JSmol)
  (verify)

3,4-Methylenedioxycathinone (also known as MDC, Nitrilone, Amylone and βk-MDA) is an empathogen and stimulant of the phenethylamine, amphetamine, and cathinone classes[1][2] and the β-keto analogue of MDA.[3]

Methylenedioxycathinone has been investigated as antidepressant and antiparkinson agent.[4]

See also

References

  1. "Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis". Forensic Toxicology 29 (2): 73–84. July 2011. doi:10.1007/s11419-011-0111-8. 
  2. "Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs". Pharmacology, Biochemistry, and Behavior 58 (4): 1109–16. December 1997. doi:10.1016/S0091-3057(97)00323-7. PMID 9408221. 
  3. Dal Cason, Terry A (May 1997). "The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs". Forensic Science International 87 (1): 9–53. doi:10.1016/S0379-0738(97)02133-6. http://www.fsijournal.org/article/S0379-0738%2897%2902133-6/abstract. 
  4. Jacob III P, Shulgin AT, "Preparation of novel N-substituted-2-amino-3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents.", WO patent 1996039133, published 12 December 1996, assigned to Neurobiological Technologies, Inc.